Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 11/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.40 |
| ▸ | RBP4 | P02753 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20714057 | 0.93 | FFAR4 (0.43) | FFAR4ALDH1A1TDP1TP53POLB | |
| SCHEMBL25969024 | 0.91 | FFAR4 (0.41) | FFAR4ALDH1A1TDP1TP53POLB | |
| SCHEMBL25969068 | 0.89 | FFAR4 (0.50) | FFAR4RBP4TTR | |
| SCHEMBL20612909 | 0.85 | FFAR4 (0.44) | FFAR4RBP4TTR | |
| SCHEMBL20613101 | 0.83 | FFAR4 (0.43) | FFAR4RBP4TTR | |
| SCHEMBL20612921 | 0.83 | FFAR4 (0.44) | FFAR4ALDH1A1TDP1TP53POLB | |
| SCHEMBL25969148 | 0.80 | FFAR4 (0.46) | FFAR4RBP4TTR | |
| SCHEMBL2691039 | 0.73 | CYP4F2 (0.50) | FFAR4ALDH1A1POLBHPGD | |
| SCHEMBL20597539 | 0.73 | ALDH1A1 (0.35) | ALDH1A1TDP1MAPTNPC1RAB9A | |
| SCHEMBL25968743 | 0.72 | FFAR4 (0.40) | FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3421454-A1 | PIPERIDINE DERIVATIVE | Otsuka Pharmaceutical Co., Ltd. (JP) | 2019-01-02 | — | — | EP | disclosed |